Your browser doesn't support javascript.
loading
The impact of the introduction of bortezomib on dialysis independence in multiple myeloma patients with renal impairment: a nationwide Dutch population-based study.
Oortgiesen, Berdien E; Azad, Roshna; Hemmelder, Marc H; Kibbelaar, Robby E; Veeger, Nic J G M; de Vries, Joost C; van Roon, Eric N; Hoogendoorn, Mels.
Afiliação
  • Oortgiesen BE; Department of Clinical Pharmacy and Pharmacology, Medical Center Leeuwarden, the Netherlands Berdien.Oortgiesen@znb.nl.
  • Azad R; Department of Clinical Pharmacy and Pharmacology, Medical Center Leeuwarden, the Netherlands.
  • Hemmelder MH; Department of Nephrology, Medical Center Leeuwarden, the Netherlands.
  • Kibbelaar RE; Department of Pathology, Pathology Friesland, Leeuwarden, the Netherlands.
  • Veeger NJGM; Department of Epidemiology, MCL Academy, Leeuwarden, the Netherlands.
  • de Vries JC; Department of Epidemiology, University of Groningen, University Medical Center Groningen, the Netherlands.
  • van Roon EN; Department of Hematology, Medical Center Leeuwarden, the Netherlands.
  • Hoogendoorn M; Unit of Pharmacotherapy, Epidemiology and Economics, Department of Pharmacy, University of Groningen, the Netherlands.
Haematologica ; 103(7): e311-e314, 2018 07.
Article em En | MEDLINE | ID: mdl-29545339
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diálise Renal / Insuficiência Renal / Bortezomib / Mieloma Múltiplo / Antineoplásicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diálise Renal / Insuficiência Renal / Bortezomib / Mieloma Múltiplo / Antineoplásicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article